Skip to main content

COSMOS Pharmaceutical Corporation

株式会社コスモス薬品

Valuation

Fundamental ratios for the latest reported period.

Ticker: 3349
FY2025 · 2026-05-31
Gross margin20.9%
Operating margin3.9%
Net margin2.9%
Return on equity11.3%
Return on assets5.4%
Revenue growth (YoY)8.7%
EPS (basic)¥404.33
EPS growth (YoY)3.4%
Current ratio0.77x
Equity ratio47.5%
Book value / share¥3,579.49
Free cash flow-11,672 M